1. Home
  2. ES vs ILMN Comparison

ES vs ILMN Comparison

Compare ES & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eversource Energy (D/B/A)

ES

Eversource Energy (D/B/A)

HOLD

Current Price

$68.04

Market Cap

27.7B

Sector

Utilities

ML Signal

HOLD

Logo Illumina Inc.

ILMN

Illumina Inc.

HOLD

Current Price

$134.20

Market Cap

18.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ES
ILMN
Founded
1927
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Electric Utilities: Central
Medical Specialities
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
27.7B
18.9B
IPO Year
N/A
2000

Fundamental Metrics

Financial Performance
Metric
ES
ILMN
Price
$68.04
$134.20
Analyst Decision
Hold
Hold
Analyst Count
12
15
Target Price
$71.25
$114.93
AVG Volume (30 Days)
3.0M
1.6M
Earning Date
11-04-2025
10-30-2025
Dividend Yield
4.42%
N/A
EPS Growth
N/A
N/A
EPS
3.65
4.46
Revenue
$13,148,536,000.00
$4,288,000,000.00
Revenue This Year
$10.10
N/A
Revenue Next Year
$4.11
$2.08
P/E Ratio
$18.69
$30.24
Revenue Growth
13.12
N/A
52 Week Low
$52.28
$68.70
52 Week High
$75.25
$153.06

Technical Indicators

Market Signals
Indicator
ES
ILMN
Relative Strength Index (RSI) 47.94 69.62
Support Level $67.06 $126.44
Resistance Level $68.84 $129.72
Average True Range (ATR) 1.10 3.59
MACD 0.28 0.08
Stochastic Oscillator 81.68 85.06

Price Performance

Historical Comparison
ES
ILMN

About ES Eversource Energy (D/B/A)

Eversource Energy is a diversified holding company with subsidiaries that provide rate-regulated electric and gas distribution service to more than 4 million customers in the Northeast US. Eversource expanded its service territories with acquisitions of NStar (2012), Aquarion (2017), and Columbia Gas (2020). In 2024 Eversource exited its 50% partnership with European utility Orsted to develop 2 gigawatts of offshore wind projects in the Northeast US. The company exited most of its unregulated businesses in 2006.

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Share on Social Networks: